Drug intelligence / Profile preview

Kenestrin Gel

Development stage
Unknown
Lead developer
Easton Pharmaceuticals
Administration
Topical
01

Overview

Kenestrin Gel is an over-the-counter topical therapeutic gel developed by Easton Pharmaceuticals for symptomatic treatment in the multi‑billion‑dollar rheumatoid arthritis market, formulated as an odourless and colorless transdermal product intended to deliver active agents through the skin to affected joints.[2][10][16] Publicly available information emphasizes its proprietary gel delivery system and positioning as a non‑prescription product for arthritis-related pain and inflammation, but specific active pharmaceutical ingredients, molecular targets, and detailed clinical data have not been disclosed.[2][10][16]

Brand names
Kenestrin Gel
Other names
Kenestrin
02

Targets

ErgosterolHCAR2 (Hydroxycarboxylic acid receptor 2)KCNN4 (Intermediate conductance calcium-activated potassium channel protein 4)CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Kenestrin Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kenestrin Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call